Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using gabapentin to treat neuropathic pain.

H Hays, M A Woodroffe

    Canadian Family Physician Medecin De Famille Canadien
    |October 6, 1999
    PubMed
    Summary

    Gabapentin, an anticonvulsant, shows promise as an effective adjuvant therapy for neuropathic pain. Its favorable pharmacokinetics and tolerability simplify treatment for various pain conditions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Home care of the frail elderly and the terminally ill.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    Hypodermoclysis for symptom control in terminal care.

    Canadian family physician Medecin de famille canadien·2011
    Same author

    High dosing methadone and a possible relationship to serious cardia arrhythmias.

    Pain research & management·2002
    Same author

    Marijuana for the management of proximal mytonic myopathy.

    Journal of pain and symptom management·2001
    Same author

    Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.

    BMJ (Clinical research ed.)·2001
    Same author

    Query "wind-down, switch-off".

    Journal of pain and symptom management·1999

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Neuropathic pain presents a significant clinical challenge.
    • Adjuvant pharmacotherapies are crucial for managing complex pain states.

    Observation:

    • Gabapentin, an anticonvulsant structurally related to gamma-aminobutyric acid (GABA), is increasingly utilized.
    • Its precise receptor binding and biochemical mechanisms in pain remain under investigation.
    • Available literature suggests gabapentin possesses favorable pharmacokinetic properties and an acceptable side-effect profile.

    Findings:

    • Gabapentin demonstrates efficacy as an adjuvant agent in treating neuropathic pain.
    • The medication is well-tolerated with minimal drug interactions, simplifying clinical application.
    • No double-blind studies specifically evaluating gabapentin as an analgesic adjuvant were identified in the reviewed literature.

    Implications:

    • Gabapentin represents a potential therapeutic option for diverse neuropathic pain conditions.
    • Further research, including double-blind trials, is warranted to fully elucidate its role in pain management.
    • The favorable tolerability profile suggests gabapentin could be integrated into multimodal pain treatment strategies.

    Related Experiment Videos